81 results
Page 3 of 5
8-K
EX-99.1
xk1z7 bra
21 Jun 21
Regulation FD Disclosure
8:15am
8-K
EX-99.1
dsa4d zm2z5ie
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.2
h1ueqnsr ecdzbga
13 May 21
Akero Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:18am
8-K
EX-99.1
ifs0wx
13 Apr 21
A Global Disease, A Pioneering Treatment Corporate Presentation April 2021
8:30am
8-K
EX-99.2
uwfhq3cta248r4g
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
2x1x5z4 w9b
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
8-K
EX-99.1
6see62q1ijp3mowg4a
16 Mar 21
Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
8:10am
8-K
EX-99.1
byg5 qzgcr
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
92ijm0h91
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
EX-99.1
wwgz02xny5wunrfs3e
12 Nov 20
Akero Therapeutics Reports THIRD Quarter 2020 Financial Results
4:20pm
8-K
EX-99.1
xtl1yvb
12 Aug 20
Akero Therapeutics Reports SECOND Quarter 2020 Financial Results
4:25pm
424B4
x0ov0mg
8 Jul 20
Prospectus supplement with pricing info
8:30pm
8-K
EX-99.1
jna6ad4rofh9win8
30 Jun 20
Akero Announces Strongly Positive Histological Data
4:16pm
8-K
EX-99.1
gh2x1a
28 May 20
Other Events
8:01am
DRS
pkcvc
15 May 20
Draft registration statement
12:00am